Auteurs
Keywords (en)
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Jacques Morel26
Severity of Illness Index32
Jacques Morel Sauf Severity of Illness Index" 23
Severity of Illness Index Sauf Jacques Morel" 29
Jacques Morel Et Severity of Illness Index 3
Jacques Morel Ou Severity of Illness Index 55
Corpus758
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000160 Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
000272 Johanna Sigaux [France] ; Moustafa Hamze [France] ; Claire Daien [France] ; Jacques Morel [France] ; Roman Krzysiek [France] ; Marc Pallardy [France] ; Bernard Maillere [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France]Immunogenicity of tocilizumab in patients with rheumatoid arthritis.
000395 Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France]High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021